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1. Introduction 
The interaction of a drug with microsomal cyto- 
chrome P-450 may cause Type I, Type II and modi- 
tied Type II difference-spectra or no spectral change 
at all [l] . Which of these effects is actually observed 
depends as well on properties of the drug - like hydro- 
phobicity and availability of lone-pair electrons - as 
on the state of the cytochrome [2]. 
The heme portion of cytochrome P-450 exists 
preferentially in a low-spin state which - under change 
of its absorbance characteristics - is partially convert- 
ed to high-spin state, when Type I binders are added 
[3]. Many Type I substrates interact so strongly with 
cytochrome P-450 that they remain bound to a 
certain degree during preparation of microsomes and 
beyond that also during purification of cytochrome 
P-450. Cytochrome.P-450 from animals treated with 
phenobarbital [4] and methylcholanthrene [5] was 
isolated in form of complexes with those substrates 
or their metabolites. 
‘Endogeneous’ substrates of that kind will com- 
plete with in vitro added Type I compounds in such 
a way that only diminished Type I binding spectra are 
observed and the apparent affinities and presumably 
the metabolism of the drugs are influenced. Reliable 
experiments on the nature of drug-cytochrome 
P-450 interactions therefore can only be performed 
with a cytochrome as far as possible free of endo- 
geneous substrates. 
The purpose of this paper is to show a simple 
method for removing substrates from cytochrome 
P-450: Incubation with charcoal leads to an extensive 
release of firmly bound ligands without any detect- 
able destruction of the cytochrome and its catalytic 
properties. 
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2. Materials and methods 
Chemicals and biochemicals of the highest purity 
available were obtained from E. Merck (Darmstadt), 
Boehringer (Mannheim), Sigma and Atlas chemical 
company. ‘H-labelled Tiamutir@*, a derivative of 
pleuromutilin, was prepared by F. Battig (Sandoz 
Forschungsinstitut) with a specific activity of 
22 &i/mg. 
If not otherwise indicated, experiments were per- 
formed in isotonic KCl/Tris buffer (50 mM Tris, 
0.12 M KCl, pH 7.4). 
Microsomes were prepared from livers of male rats 
(Sprague-Dawley, 200 g) and rabbits (New Zealand, 
1.5 kg) as previously described [6]. Cytochrome 
P-450 from rabbit liver was partially purified about 
3 times by the procedure of Van der Hoeven and 
Coon [7]. Its content was determined using the 
method of Omura and Sato [8] protein was measured 
according to Lowry [9]. The metabolizing activities 
of microsomes were checked by their ability to 
hydroxylate aniline and demethylate aminopyrine 
[lO,ll]. 
Charcoal was activated by heating it gently in 
0.25 M NaEDTA at 90°C for 1 h. Afterwards it was 
washed with excess volume of distilled water and 
finally suspended in KCl/Tris buffer to a storage sus- 
pension of 100 m&l. For the removal of cytochrome 
P-450-bound substrates aliquots of freshly prepared 
charcoal suspension were put either to microsomes or 
to partially purified cytochrome P-450 (final concen- 
tration of cytochrome P-450 in both cases about 
* 14-deoxy-14((2’-diethyl-aminoethyl)-mercaptoacetoxy)- 
mutilin hydrogen fumarate. 
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10 /AM). The resulting suspensions were stirred at 0°C 
usually for 20 min and afterwards charcoal was 
removed by centrifugation at 11 000 X g for 10 min. 
In order to determine the extent of released sub- 
strate, a Type I binder, 3H-labelled Tiamuti@, was 
added to microsomes (initial Tiamutir&oncentration 
0.1 mM). The charcoal concentration was varied 
between 0.12 and 2.4 mg/mg microsomal protein. 
After 10, 20,40 min incubation at O’C samples 
were centrifuged and the remaining radioactivity in 
the supernatant determined. Simultaneously the 
content of protein, cytochrome P-450 and its meta- 
bolizing activities were measured. 
The spectral changes produced by addition of 
TiamutinR to microsomes and partially purified cyto- 
chrome P-450 at 25’C were recorded on a Perkin 
Elmer EPS-3T spectrophotometer, as described in [6]. 
3H-radioactivity measurements were performed in 
Instagel (Packard Instruments GmbH) on a Packard 
Tri-Carb 3375 liquid scintillation spectrometer. 
3. Results and discussion 
In order to demonstrate the charcoal mediated 
release of cytochrome P-450 bound ligands we used 
the antibiotic Tiamutir@ as a probe which interacts 
exclusively in Type I manner at low drug concentra- 
tions (K,> 1 PM-‘, KCl/Tris buffer, 25’C). At elevat- 
ed Tiamuti@ concentrations (C > 20 PM) the forma- 
tion of Type I complex is followed by the emergence 
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Fig. 1. Removal of microsomal bound [ 3H] Tiamutis by 
charcoal at 0°C in KCl/Tris buffer (pH 7.4). Microsomes from 
rat liver (cytochrome P-450 10 MM). Charcoal concentration 
a 0.12 mg/mg microsomal protein,0 0.59 mg/mg microsomal 
protein01.15 mg/mg microsomal proteinm2.4 mg/mg 
microsomal protein. TiamutinR, total concentration of Tia- 
mutin’ in the supernatant after sedimentation of charcoal 
of modified Type II complex. ([ 12,131 and [6] 
describe the very similar properties of hydrated Tia- 
mutinR.) As we could show by stopped-flow kinetics 
this latter spectral change is obviously caused by a 
conformational change of the cytochrome. It is 
Table 1 
Some properties of charcoal treated microsomes from rat liver 
Contents/activities 
Protein (mg/g liver) 
Cytochrome P-450 
(nmol/mg protein) 
Hydroxylation of aniline 
(nmol/min/mg protein) 
Demethylation of amino- 
pyrine 
(nmoles/min/mg protein) 
Control After charcoal treatmenta 
11.6 8.8 
0.76 0.80 
0.70 0.87 
6.3 9.9 
a2.4 mg charcoa.l/mg protein, 20 min 
Some properties of charcoal treated microsomes from rat liver. Microsomes from 
rat liver (cytochrome P-450,10 PM) treated with 2.4 mg charcoallmg protein, 
20 min. 
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probably due to high enrichment of the compound 
in the phospholipid bulk of microsomal membranes 
respectively around the enzyme itself [ 131. 
Dependent on charcoal concentration, [ 3H] Tia- 
mutinR is removed from its unspecific phospholipid 
binding sites and from cytochrome P-450 (fig.l). 
At the highest charcoal concentration less than 0.0 16 
m/mol cytochrome P-450 remain bound, whereas -
calculated on the basis of difference spectra between 
420 and 490 nm [14] - at least 0.1-0.15 m/mol 
cytochrome P-450 had been complexed in Type I 
manner before. The small amount of ligand still bound 
was largely released by repeated treatment with 
charcoal. 
Charcoal treatment does neither denature cyto- 
chrome P-450 significantly nor diminish its catalytic 
activities (table 1). In most cases a slight increase of 
relative cytochrome P-450 content was observed - 
presumably due to removal of non-microsomal protein 
by charcoal. The high increase of demethylating activity 
is obviously caused by a release of some endogeneous 
inhibitor. 
Tiamuti@ was also used as a probe for the spectral 
properties of cytochrome P-450: Charcoal treatment 
leads to highly increased Type I difference spectra. 
This was proved with microsomes from rat and rabbit, 
of control and phenobarbital or methylcholanthrene 
induced animals. Cytochrome P-450 - partially puri- 
fied from rabbits after [7] has lost some Type I sites 
during purification‘- presumably due to detergent 
binding. Charcoal treatment enhances the magnitude 
of Type I spectra very markedly (fig.2A). Evaluation 
of the binding isothermes shows that the number of 
Type I sites has doubled and the apparent affinity is 
increased about 4-times from 0.06-0.25 PM-’ at 
25’C (in KCl-Tris/Tris acetate glycerol). In contrast 
the modified Type II spectrum observable at high 
TiamutinR concentrations is not influenced by charcoal 
treatment (fig.ZB). 
This result is in accordance with the assumption 
that the conformational change of the cytochrome 
[ 131 which leads to modified Type II emergence is 
mediated by TiamutinR-phospholipid interactions. 
(A certain amount of phospholipid adhered to the 
protein also in the partially purified preparation 
[ 121.) This type of interaction should not depend so 
much on the nature of Type I ligand. 
‘Endogeneous’ substrates will inhibit the binding 
J 1 , 
0.02 0.04 00s 
Fig.2. Titration of partiall 
Ih 
purified cytochrome P-450 from 
rabbit liver with Tiimutin before and after charcoal treat- 
ment (pH 7.4, buffer = 40% KCl/Tris, 60% Tris-acetate- 
glycerol, Tris acetate 10 mM, glycerol 20%, EDTA 0.1 mM). 
(a-e) Before charcoal treatment, (o-o) after 2.4 mg 
charcoal/mg protein, 20 min CP_,~ = 9.0 PM (3.0 
protein). TiamutinR , total concentration of 
Type I spectrum, (B) modified Type II spectrum. 
as well as the metabolism of a certain drug to an 
unknown degree. Their removal seems to us a crucial 
prerequisite before starting an experiment. The use 
of charcoal for this purpose has some advantage over 
the use of albumin as proposed by Holtzman et al. 
[4]. Activated charcoal can easily be prepared in a 
standard quality whereas albumin may have bound 
varying amounts of minor components like fatty acids 
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which can dissociate drugs from cytochrome P-450. 
Endogeneous substrates are removed together with 
the charcoal from the sample under investigation. No 
coupled equilibria, as in the case of ligand binding 
to the cytochrome and albumin, have to be considered. 
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